← Eichor
Study identifier: NCT07451470 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Comparison of Gastric Insufflation Volume Between LarySeal Pro and Ambu AuraGain Using Ultrasonography In Pediatric Patients Undergoing General Anesthesia With Controlled Ventilation.

Condition: Gastric Insufflation  ·  Sponsor: Cairo University

PhaseNA
Planned participants106
Who can joinAll sexes, 6 Years to 10 Years
Healthy volunteersYes

About this study

Gastric air insufflation during insertion of a laryngeal mask airway (LMA) is a known phenomenon and can have important clinical implications, especially in relation to: During positive pressure ventilation or improper insertion technique, air can be forced into the esophagus and stomach or LMAs do not fully seal the esophagus, so high ventilation pressures or incorrect placement may lead to gastric insufflation. Which may lead to Increased risk of regurgitation and aspiration, especially if the gastric contents reach the upper esophagus, Abdominal distension, which can reduce ventilation efficiency, nausea, vomiting, or delayed gastric emptying postoperatively which detected by Epigastric auscultation may reveal gurgling sounds during ventilation, Gastric ultrasound can visualize the extent of gastric insufflation and Capnography sometimes shows altered patterns if regurgitation begins . This complication prevented by: * Use low-pressure, controlled ventilation (\<20 cmH₂O). * Ensure proper size and positioning of the LMA. * Use second-generation LMAs (like LarySealPro or Ambu AuraGain LMA) that have gastric drainage ports to relieve air. Consider gastric ultrasound preoperatively to assess risk . (1) Several studies have assessed the performance of Ambu AuraGain and LarySeal Pro individually or in comparison with other supraglottic airway devices. Ambu AuraGain, a second-generation device with a gastric drainage channel, has demonstrated high oropharyngeal leak pressures…

This description comes directly from the study's public registry record.

Talk to the study team

dr mahmoud abdeltawab gbre, lectrer MD  ·  +020109772251  ·  mahmoud15588@gmail.com

dr sherif soida, assistant proffesour  ·  +02 01223663504

Always discuss trial participation with your own doctor first.

Locations (1)

Cairo UniverstyCairo, Cairo Governorate, EgyptRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07451470